Clinical trial
Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage: A Randomized, Double-masked, Controlled Study
NCT01030770 is registered in ClinicalTrials.gov with King's College Hospital NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage: A Randomized, Double-masked, Controlled Study
- Lead sponsor
- King's College Hospital NHS Trust
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- May 31, 2016
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.